Our Research

Shares of KNTK have plunged ~38% YTD, fueling a spike in client inbounds and igniting one of the hotter debates in Permian Midstream (M&A). The key question: Is KNTK a willing seller, or is management…

…Specifically, if KNTK would be a seller at these levels. It all depends (Call us). Shares are down ~38% YTD. Naturally, we ran a full accretion/ dilution analysis featuring 15 potential buyers for KNTK out…

source: The Schneider Capital Group We just scraped the entire internet (X, Reddit, StockTwits, blogs, forums – everything) for the ~200 energy, utility, and chemicals issuers we track. The result: We identify the 20 stocks…

Within, we present a full accretion/dilution breakout (EPS/FCF/EBITDA/Leverage) for 18 targeted Chemicals M&A deals – sharpened from our initial matrix of ~100 hypothetical combinations (link). Why the urgency? Q3 earnings confirm the chemical sector’s deep…

For the news, we include a brief summary description for each headline. We only include links to news sources that do NOT require you to have a subscription to the respective site, or if they do, they are free of charge. However,…

Esentia Energy Development’s IPO (finally) priced – at 45 pesos per share, a steep 26% discount to the original mid of the 50- 72 peso range. Not entirely a shock… but plenty of blame to…

Our recent client conversations on natural gas reflect the widest – and most fiercely opinionated – divide seen in years. From rapid-fire near-term trading to 2026+ macro scenarios, LNG expectations have polarized the market drawing…

Within we provide a uniquely comprehensive, cross-sector lens on the entire energy, utility, and chemicals universe – quantifying where each segment stands in terms of price momentum, valuation, and market-implied upside. By combining technical positioning…

Thoughts on DevTerra? source: The Schneider Capital Group; The Internet Over the weekend, we published a comprehensive accretion/dilution analysis on a hypothetical merger of equals between DVN and CTRA – zero premium, all equity, with full…

Because… who knows what will happen into year-end (or beyond)! Why now? We spent a lot of time digesting chemical earnings over the past few weeks. Both from pure play chemical companies (speciality & commodity)…

Effective immediately (and with Q3 earnings in the rear-view mirror), we are closing our Q3 earnings portfolio (‘Most Loved & Hated: link‘) for a median return of ~9% (average ~8%). Full portfolio positions within. The…

Summarizing key chatter and high-level discussions… Within we focus on: Topical stock discussions and key macro/ industry themes to were front and center last week. This week we cover IEA Pushes Out ‘Peak Oil’; CVX Analyst…

Activist Kimmeridge is now active in both Devon Energy and Coterra Energy – most recently surfacing via a disclosed stake in Devon on Friday (following the open letter to CTRA earlier this month). The combination…

For the news, we include a brief summary description for each headline. We only include links to news sources that do NOT require you to have a subscription to the respective site, or if they do, they are free of charge. However,…

Yes; Depends; Yes (slam-dunk buying COP)/ Yes (looks good in excel with BP – other hurdles)/ Eh – We’re ok w/o OXY. Just a few casual thoughts ahead of the CVX Analyst Day tomorrow. We…